A 29-year-old women presents with primary intrathyroidal papillary thyroid carcinoma (BRAF VE1 positive) with morphologically recognizable metastases to cervical lymph nodes (BRAF VE1 positive) as well as a focus of bland-appearing thyroid follicles within the capsule of a level II lymph node (BRAF VE1 negative). There exist various theories regarding the possible developmental origins of "benign" intranodal thyroid tissue in the lateral neck. While the true nature of the bland follicles may not be definitively resolved in this case, these findings are suggestive that they do not represent metastasis from the main papillary thyroid carcinoma. Additional insight into this unusual phenomenon may be gathered by more specific clonal analysis of these microscopic foci.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/10668969211033526 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intranodal thyroid inclusions revisited: a morphological analysis and application of BRAF VE1 immunohistochemistry.
Histopathology
December 2024
Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Article Synopsis
- The study investigates intranodal thyroid inclusions (ITIs) and their clinicopathologic characteristics, aiming to clarify their diagnosis through immunohistochemistry (IHC).
- The research included 41 cases of ITIs, with a higher incidence found in patients with papillary thyroid carcinoma (PTC) compared to those with other cancers, highlighting significant differences in nuclear features between ITIs and metastatic PTC.
- The findings suggest important diagnostic criteria for ITIs, emphasizing their potential clinical significance in differentiating between benign inclusions and metastatic cancer.
Molecular-Guided Therapy for Melanoma in Canada: Overview of Current Practices and Recommendations.
J Cutan Med Surg
December 2024
Department of Diagnostic and Molecular Pathology, Memorial University of Newfoundland, Health Sciences Centre, St. John's, NL, Canada.
The emergence of pathologist-driven molecular reflex testing for tumoural biomarkers is a significant advancement in cancer diagnostics, facilitating targeted cancer therapy for our patients. Based on our experience, the Canadian landscape of pathologist-driven reflex biomarker testing for melanoma lacks standardization and is plagued by a lack of awareness by pathologists and clinicians. This paper comprehensively examines the approaches to reflex biomarker testing for melanoma patients across Canada, highlighting the regional variations in the criteria for initiating molecular testing, the biomarkers tested, and the molecular techniques employed.
View Article and Find Full Text PDFExpression of Mutated Kinase in Canine Carcinomas-An Immunohistochemical Study.
Vet Sci
November 2024
Institute of Animal Pathology, COMPATH, University of Bern, 3012 Bern, Switzerland.
Alterations of the gene and the resulting changes in the BRAF protein are one example of molecular cancer profiling in humans and dogs. We tested 227 samples of canine carcinomas from different anatomical sites (anal sac ( = 23), intestine ( = 21), liver ( = 21), lungs ( = 19), mammary gland ( = 20), nasal cavity ( = 21), oral epithelium ( = 18), ovary ( = 20), prostate ( = 21), thyroid gland ( = 21), urinary bladder ( = 22)) with two commercially available primary anti-BRAF antibodies (VE1 Ventana, VE1 Abcam). The immunohistochemical results were confirmed with droplet digital PCR (ddPCR).
View Article and Find Full Text PDFIncidentally Detected ALK-Positive Histiocytosis with Fusion in a Solitary Pulmonary Nodule Following COVID-19 Infection: A Rare Case Report.
Int J Surg Pathol
September 2024
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
We hereby report a patient with ALK-positive histiocytosis with localized lung involvement. A 47-year-old woman presented with a solitary pulmonary nodule in the left upper lobe, 7 months after COVID infection. A well-defined 15 mm yellow mass was found in trisegmentectomy specimen.
View Article and Find Full Text PDFDifficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma.
Case Rep Endocrinol
May 2024
School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Background: Cribriform morular thyroid carcinoma has been recently renamed in the 2022 WHO classification as a thyroid tumor of uncertain histogenesis. The epidemiologic, pathological, and pathophysiological characteristics distinguish it from papillary thyroid carcinoma (PTC). Preoperative genetic testing plays a role in facilitating the differential diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!